Loading organizations...
Key people at Advanced Research Projects Agency for Health.
The Advanced Research Projects Agency for Health (ARPA-H) functions as a federal funding agency, accelerating transformative biomedical and health breakthroughs. It prioritizes high-risk, high-reward research initiatives often overlooked by conventional funding. ARPA-H programs span foundational science to translational medicine, developing capabilities and platforms to address health issues with societal impact.
ARPA-H was established on March 15, 2022, as an independent entity within the U.S. Department of Health and Human Services. Its creation arose from a need to propel ambitious health research, inspired by the DARPA model for defense innovation. It bridges gaps in the health research ecosystem by fostering bold, interdisciplinary approaches to complex problems.
ARPA-H seeks to improve health outcomes for all by catalyzing discoveries across diverse research sectors. It supports innovators in academia, industry, and non-profits, enabling solutions for pervasive health challenges. Its long-term vision is to reshape disease prevention, detection, and treatment nationwide, ultimately transforming the health and welfare of the American populace.
Key people at Advanced Research Projects Agency for Health.
Advanced Research Projects Agency for Health has 4 tracked investments across 4 companies. The latest tracked deal is $15.0M Grant in Seaport Therapeutics in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 4, 2026 | Seaport Therapeutics | $15.0M Grant | Advanced Research Projects Agency For Health | — |
| Oct 6, 2025 | Owlstone Medical | $49.1M Grant | Advanced Research Projects Agency For Health | — |
| Sep 10, 2024 | Cellino | $25.0M Grant | Advanced Research Projects Agency For Health | — |
| Mar 14, 2024 | Thymmune Therapeutics | $37.0M Other Equity | Advanced Research Projects Agency For Health | — |